EIF4G2 and ovarian cancer: Paclitaxel-resistant ovarian cancer cells not only enhanced invasion and migration (Figure 6a-b) but also increased the expression of MMP2 and 9 in inducing the overexpression of EIF4G2 (Figure 6c-d) when compared to SiRNA- SNHG7 group.